Biolase Inc
(BIOLQ)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Sales | 8,520 | 6,539 | 2,938 | 4,783 | 10,182 |
| Cost of Goods | 6,915 | 4,265 | 1,997 | 3,430 | 5,765 |
| Gross Profit | 1,605 | 2,274 | 941 | 1,353 | 4,417 |
| Operating Expenses | 8,058 | 6,206 | 5,917 | 7,135 | 8,220 |
| Operating Income | -5,538 | -3,667 | -3,979 | -5,352 | -3,038 |
| Interest Expense | 577 | 568 | 625 | 589 | 599 |
| Other Income | 56 | 4,262 | -40 | -84 | -54 |
| Pre-tax Income | -6,059 | 27 | -4,644 | -6,025 | -3,691 |
| Income Tax | 79 | 15 | 53 | -19 | -113 |
| Net Income Continuous | -6,138 | 12 | -4,697 | -6,006 | -3,578 |
| Net Income | $-6,138 | $12 | $-4,697 | $-6,006 | $-3,578 |
| EPS Basic Total Ops | -99.00 | -525.00 | -300.00 | -475.00 | -275.00 |
| EPS Basic Continuous Ops | 96.95 | 0.37 | -309.09 | -476.53 | -267.54 |
| EPS Diluted Total Ops | -99.00 | -525.00 | -300.00 | -475.00 | -275.00 |
| EPS Diluted Continuous Ops | 96.95 | 0.37 | -309.09 | -476.53 | -267.54 |
| EBITDA(a) | $-5,433 | $-3,460 | $-3,569 | $-5,079 | $-2,715 |